<DOC>
	<DOCNO>NCT00701532</DOCNO>
	<brief_summary>-Context : Study objectives Primary : impact modafinil versus placebo DAT density modification striatal extra-striatal region cocaine dependent subject hospitalise D3 D21 . Primary Hypothesis : More rapid normalisation DAT concentration measure PET use modafinil versus placebo D3 D21 cocaine detoxification .</brief_summary>
	<brief_title>Brain Imaging Study Effects Modafinil Cocaine Addiction</brief_title>
	<detailed_description>Context : Cocaine dependence disorder rapidly progressive evolution , associate various complication . Because cocaine 's direct action dopamine transporter ( DAT ) , dopaminergic system dysregulation play fundamental role reinforcement phenomenon dependence . This proven numerous animal post-death human study striatal DAT . In vivo study cocaine dependent patient rare . Currently pharmacotherapy available treat pathology . Current study indicate pharmacological agent modafinil may able reverse neuroadaptations induced cocaine dependence . However , functional neuroimaging study ( Positron Emission Tomography , PET ) analyse impact medication DAT density cocaine dependent patient . However , primate , vivo PET show modafinil affinity DAT . Primary Hypothesis : More rapid normalisation DAT concentration measure PET use modafinil versus placebo D3 D21 therapeutic cocaine withdrawal . Study objectives Primary : impact modafinil versus placebo DAT density modification striatal extra-striatal region cocaine dependent subject hospitalise D3 D21 . Secondary : Evaluation clinical efficacy modafinil therapeutic cocaine withdrawal . Correlation crave measurement , depressive symptom measurement cognitive deficit measurement observe modification DAT density . Study DAT D3 D21 versus pre-existing data base control subject . Tolerance safety evaluation high modafinil dos , measure adverse event biological parameter . Calculation number subject : A power 90 % find number subject estimate 24 ( bilateral test , Î± risk 5 % , estimate SEM 5 % , variation occupational concentration DAT expect least 12 % modafinil group ) . Considering usual rate patient lose follow-up patient population ( 25 % ) , plan include 30 patient . Methodology : This study regulate law biomedical research August 9 , 2004 . It randomise monocentric double blind study versus placebo . During study , 90 day , patient receive double blind either modafinil placebo accord randomisation arm . Evaluations include 2 PET , cerebral MRI , blood work-up , urinary toxin screen , clinical scale crave , depression neuropsychological evaluation . Patients recruit 24 month . The total study length 36 month . Primary judgment criterion : Variation link potential ( specific fixation rate radioligand [ 11C ] -PE2I DAT ) TEP measurement D3 D21 within various anatomical region interest 2 group ( modafinil , placebo ) . Expected Results : Decreased DAT occupation rate modafinil group versus placebo D3 D21 withdrawal .</detailed_description>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Men least 18 year age Cocaine dependent accord DSM IV TR criterion Seeking treatment Capable understand give informed write consent With National Health coverage Urinary screen positive cocaine week prior inclusion Women Other DSM IV TR axe I diagnostic criterion ( except tobacco ) Neurological disorder Treatment interfere DAT modafinil Contraindications modafinil Magnetic Resonance Imaging</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Cocaine</keyword>
	<keyword>Substance abuse</keyword>
	<keyword>Addiction</keyword>
	<keyword>Dependence</keyword>
	<keyword>Modafinil</keyword>
	<keyword>Brain imaging</keyword>
</DOC>